Yi-Zhen Huang1,2
Zheng Jin1,2Zhe-Ming Wang1,2Li-Bo Qi1,2
Shuang Song1,2Bei-Wei Zhu1,2
Xiu-Ping Dong1,2*- 1School of Food Science and Technology, Academy of Food Interdisciplinary Science, Dalian Polytechnic University, Dalian, China
- 2National Engineering Research Center of Seafood, Collaborative Innovation Center of Seafood Deep Processing, Liaoning Province Collaborative Innovation Center for Marine Food Deep Processing, School of Food Science and Technology, Dalian Polytechnic University, Dalian, China
Oral diseases have received considerable attention worldwide as one of the major global public health problems. The development of oral diseases is influenced by socioeconomic, physiological, traumatic, biological, dietary and hygienic practices factors. Currently, the main prevention strategy for oral diseases is to inhibit the growth of biofilm-producing plaque bacteria. Tooth brushing is the most common method of cleaning plaque, aided by mouthwash and sugar-free chewing gum in the daily routine. As the global nutraceutical market grows, marine bioactive compounds are becoming increasingly popular among consumers for their antibacterial, anti-inflammatory and antitumor properties. However, to date, few systematic summaries and studies on the application of marine bioactive compounds in oral health exist. This review provides a comprehensive overview of different marine-sourced bioactive compounds and their health benefits in dental caries, gingivitis, periodontitis, halitosis, oral cancer, and their potential use as functional food ingredients for oral health. In addition, limitations and challenges of the application of these active ingredients are discussed and some observations on current work and future trends are presented in the conclusion section.
Introduction
Oral and periodontal diseases can determine severe functional, phonatory and aesthetic impairments and are the main cause of adult tooth loss (1). According to statistics, the number of people suffering from untreated dental caries, severe periodontitis and oral diseases has reached 3.5 billion worldwide (2, 3). Moreover, the number of cancers occurring in the lips and oral cavity reached 377,713 in 2020, based on GLOBOCAN statistics (4). Oral diseases have become a major global public health problem. The growing awareness of the oral health benefits has compelled science and industry to conduct research on nutrients for the prevention and treatment of oral diseases, including isolated nutrients and compounds as dietary supplements. The marine-sourced compounds include protein and peptides, protein, ω-3 polyunsaturated fatty acids (PUFA), polysaccharides, polyphenolic compounds, enzymes, vitamins and pigments (5) with a wide range of physiological activities such as antitumor, antioxidant, antiviral, and immunomodulatory activities (6, 7). Thus, the wide variety of marine species is not only a source of important active compounds for the treatment and prevention of various diseases, but also a potential source of ingredients for oral health maintenance (8–10).
Indeed, bioactive materials and molecules from marine sources have been applied in many potential research areas in dental science. Shaikh et al. (11) conducted a review on the application of marine derived ingredients such as chitosan, bio-adhesives, tissue regeneration gel, calcium hydroxyapatite, gypsum and algal extracts in the field of dentistry. Ibrahim et al. (12) found that marine bioactive ingredients have inhibitory effects on Streptococcus mutans (S. mutans) and can be used to maintain dental health. In recent years, various scientific research publications on marine bioactive ingredients health benefits and the development of marine nutraceuticals have been published. Two hundred and ninety-eight papers related to marine bioactive compounds and oral disease published in the past 18 years were retrieved from Science Direct and analyzed by Vosviewer for keywords (marine bioactive compounds, oral disease/disorder/health). The results of the co-occurrence analysis showed that the research related to the effects of marine bioactive compounds on oral health gradually shifted to periodontitis, dental plaque, phytotherapy and functional food. Figure 1 shows the overlay visualization of keyword statistics.
Figure 1. Overlay visualization of keyword statistics.
Published reviews with a comprehensive description of marine bioactive compounds as nutritional and functional food ingredients for potential oral health are limited. Therefore, it is necessary to systematically summarize the benefits, risks and prospects of marine bioactive compounds in oral health applications. This review provided a comprehensive overview of different marine bioactive compounds and their health benefits, as well as their potential to be used as functional food ingredients for oral health. In addition, the limitations and challenges of the application of these active ingredients were discussed and some perspectives on the current work and future trends were presented in the conclusion section.
Oral Health
Oral Health, Plaque and Microbiome
Oral health is an important indicator of people's overall health and quality of life. The World Health Organization (WHO) defines oral health as “a state of being free from chronic mouth and facial pain, oral and throat cancer, oral infection and sores, periodontal (gum) disease, tooth decay, tooth loss, and other diseases and disorders that limit an individual's capacity in biting, chewing, smiling, speaking, and psychosocial well-being” (13, 14). Recent years, oral epidemiology is shifting globally and the main oral disorders that plague people's lives include: dental caries, periodontal disease, oral cancer, oral manifestations of HIV, oro-dental trauma, cleft lip and palate, and Noma (13, 14). Oral diseases can lead to pain, impaired function and reduced quality of life, which can have a direct impact on an individual's quality of life (15).
Plaque in the oral cavity is considered to be the basis for the initiation and development of dental caries and periodontitis. Plaque consists of a large number of bacteria, intercellular material, a small amount of white blood cells, shed epithelial cells and food debris, and is a bacterial biofilm that cannot be washed away by water. In dentistry, biofilms are defined as microbial communities of surface-attached cells embedded in a self-produced extracellular matrix (16–19). Dental plaque biofilms on the tooth surface form a bacterial envelope that is coordinated and balanced with the surrounding tissues (16). The development of biofilm formation was shown in Figure 2 (16, 17). Dental plaque biofilms have the ability to interact in a complex interplay with the innate immune and inflammatory networks that ensure the maintenance of the host's health (20).
Figure 2. Biofilm formation.
Indeed, the development and progression of oral disease is largely influenced by oral microbiome in the oral cavity (21–26). A variety of microorganisms collectively influence the microecological balance of the oral cavity through symbiotic “competitive” antagonism (15). Many of these microorganisms are harmless; a few, such as S. mutans, Actinomyces sp., Treponema denticola, Tannerella forsythia, Bacteroides sp., A. actinomycetemcomitans, Staphylococcus intermedius, Porphyromonas gingivalis and Candida albicans, can cause oral infections (15). Moreover, factors such as immunity weakening or steroid treatment can disturb the balance of oral bacteria and can also cause opportunistic infections. Nutritional deficiencies can also alter the composition of the oral microbiome and lead to oral health problems (27). Any process resulting in weakened immunity or a factor such as steroid therapy that disturbs the oral bacterial homeostasis can cause opportunistic infections (28). Deficient diet can also alter the composition of the oral microbiome leading to oral diseases such as dental caries and periodontitis. Therefore, to ensure oral health, the oral cavity needs regular care and maintenance.
Oral Health Maintenance
Mechanical oral hygiene aid is an important way to maintain oral health (29). The most common mechanical oral cleaning is toothbrushing, but this method is not appropriate for removing plaque from the gingival sulcus of normal dentition (30, 31). Hence, regular toothbrushing needs to be accompanied by some supplementary modalities for plaque removal. Mouth rinses and chewing gum are oral cleaning aids used in the daily routine (14, 32, 33). Rinses wash the mouth quickly by mechanically flushing, making it impossible for plaque to accumulate on the teeth. Anti-inflammatory compounds such as chlorhexidine, dextranase, menthol, and triclosan are used in the treatment of oral diseases, but can lead to side effects with long-term use (34). Calvo-Guirado et al. (35) compared the effectiveness of 0.20% chlorhexidine with Sea 4® Encias (seawater) oral rinse. Based on this study, the use of seawater mouthwash had similar antimicrobial activity to chlorhexidine. Despite the better clinical performance of chlorhexidine, seawater mouthwash can reduce side effects such as tooth staining and become a daily option for maintaining oral health. Chewing gum, on the other hand, increases the secretion of saliva in the mouth through the mechanical stimulation of chewing motion, rinsing the mouth and removing of dietary fermentable carbohydrates and plaque from the mouth. Moreover, the base of chewing gum is highly sticky, which further removes plaque from the teeth. Although sugar-free chewing gum can be used as an adjunct to brushing and can significantly and slightly reduce plaque production, there is no significant improvement in gingivitis (36). Based on these characteristics, if functional ingredients with the ability to resist S. mutans strains [e.g., quercetin (Qt)] are added to chewing gum formulations, chewing gum may be used as a delivery and retention of bioactive molecules in a particularly effective way, with potential anti-caries effects. Besides cleaning, the central role of diet, natural agents and nutrition is also considered to be indirectly responsible for the health of periodontal tissues and the fight against resorption of alveolar bone resorption (27, 37).
Research Progress on Marine Bioactive Compounds in Oral Health
With the improvement of biological separation and purification technology and the in-depth research of marine biochemical drugs, an increasing number of marine bioactive substances have been isolated and identified (38–49). Now, more than 4,000 marine bioactive compounds have been isolated, but only a small number of them have been intensively studied and exploited (50). In terms of chemical structure, marine bioactive substances mainly include peptides, polysaccharides, alkaloids, terpenoids, macrocyclic polyesters, polyethers, polyenes, unsaturated fatty acids and steroids (6, 7, 51, 52). Table 1 summarizes the various marine bioactive ingredients used to prevent and treat oral diseases ranging from dental caries to halitosis.
Table 1. List of marine active ingredients for various oral diseases and their causative pathogens.
Delay the Development of Dental Caries by Inhibiting S. mutans
Dental caries, often referred to as cavities or tooth decay, can be defined as the localized chemical dissolution of tooth surfaces due to an imbalance in the oral microbial community (15, 53). According to the Global Oral Health Data Bank, the global prevalence of dental caries ranges from 49 to 83% (54), with ~486 million children suffering from primary caries and 2.4 billion children suffering from permanent caries (55). S. mutans, the main causative agent in the development of dental caries, has the ability to synthesize extracellular glucans exclusively from dietary sucrose (56–58). The main marine bioactive ingredients that are currently used to slow down the development of dental caries by inhibiting the development of S. mutans are alginate, sulfated polysaccharides, microalgae extracts, and glucanases from marine bacteria. These bioactive components inhibit the development of S. mutans by reducing sugar utilization, antibacterial and eliminating biofilms.
Alginate is used to slow down the development of dental caries by reducing the use of sucrose by S. mutans. As a non-reducing sugar extracted from seaweed, alginate can be added to foods as a sucrose substitute to slow down the development of dental caries (59). However, alginate did not completely prevent the development of dental caries and showed no effect in disrupting the biofilm formation of S. mutans (60). In contrast, fucoidan (Fucus vesiculosus F85) possessed notable antimicrobial activities against S. mutans, but no biofilm elimination was observed in the study of Jun et al. (61). Microalgae such as Dunaliella salina and Chlorella vulgaris have antimicrobial activity and are widely used in food, coloring and dietary supplements. Jafari et al. (62) showed that certain concentrations of C. vulgaris and D. salina extracts had the ability to inhibit not only S. mutans but also biofilm formation. The mechanism for the anti-biofilm activity of C. vulgaris and D. salina may be due to the glucosyltransferase (GTF) inhibition of C. vulgaris and D. salina extracts activity, which prohibits the biosynthesis of water-insoluble glucans.
Dextranase from marine bacteria are also known to prevent biofilm formation in S. mutans. Ren et al. (63) showed that Cadex, an alkaline and cold-adapted endo-type dextranase from marine bacteria, impeded the formation of S. mutans biofilms to some extent by specifically cleaving the α-1,6 glycosidic bond. Meanwhile, Lai et al. (64) screened strains of Catenovulum agarivorans MNH15 from marine samples, which produced a dextranase with stable S. mutans inhibition, and its activity was not affected by sodium fluoride, xylitol, and sodium benzoate in dental care products. Therefore, more marine bacterial dextranases can be explored for the development of oral care products or novel marine agents for the treatment of dental caries to meet the vast demand for caries prevention.
Managing Gingivitis: Compounds, Underlying Mechanism
Gingivitis is one of the most common periodontal diseases, and clinically gingivitis can be divided into two categories (29, 65): (1) gingival diseases caused by non-plaque biofilms, which do not resolve even after plaque removal and may manifest as a systemic disease or in the local oral cavity. (2) Another class is plaque-induced gingivitis, caused by the interaction of plaque biofilm and the host's immune response. The infection remains contained in the gingiva and does not extend to the periodontium, but it can be reversed by reducing plaque at the gingiva and root canals (15, 65). Plaque-induced gingivitis has many clinical features and is mainly predicated on the presence or absence of bleeding at the time of probing. Hence, the main parameters for the determination of gingivitis are GI (Gingival Index) and BOP (Bleeding on probing) (65). The main marine bioactive ingredients that have been reported for anti-gingivitis are sea cucumber extract, algae extract and n-3 polyunsaturated fatty acids (PUFAs).
Research by Wen (66) showed that toothpastes containing sea cucumber extracts were effective in reducing gingivitis. Moreover, sea cucumber Stichopus horrens (SH) extracts can promote gingival tissue healing in addition to its anti-streptococcal ability. A study by Bakar et al. (67) showed that a 9% concentration of SH-containing toothpaste (SHCT) was effectively in reducing gingival inflammation (14 days of continuous use) and probe bleeding (30 days of continuous use). The anti-inflammatory effect was also observed with Enteromorpha linza, a green algae whose extract strongly inhibited the growth of Prevotella intermedia and Porphyromonas gingivalis (68). Cho (68) determined that the anti-inflammatory effect of E. linza was reduced by plaque index (PI), GI, and BOP measured the clinical effect of mouthwash with E. linza extract on gingivitis disease. The results indicated that mouthwash containing E. linza extract had a significant inhibitory effect on gingival abscesses P. gingivalis and P. intermedia, had a significant reduction in plaque, improved gingival tissues, and reduced bleeding. Hence, the measure of using E. linza extract mouthwash twice daily was recommended by this clinical study to manage gingivitis.
Furthermore, the anti-inflammatory effects of n-3 PUFAs from marine organisms such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (Figure 3) on gingiva have been demonstrated in animal models. Campan et al. (69) showed that n-3 PUFAs was able to induce a trend toward reduced inflammation. This is because EPA may show anti-inflammatory effects by competitively inhibiting the pro-inflammatory cyclooxygenase-1/2 (COX-1/2), forming PGE2 and producing PGE3. Notably, DHA inhibits lipoxygenase (LOX) to produce the pro-inflammatory COX metabolite D-series aminotransferases, thus exhibiting a more potent inhibitory effect on inflammation than EPA. Moreover, n-3 PUFAs has antimicrobial activity. Ribeiro-Vidal et al. (70) demonstrated that DHA and EPA were more effective in this biofilm model of Streptococcus oralis, Actinomyces naiveus, Veillonella parvula, Fusobacterium nucleatum, P. gingivalis, and Aggregatibacter actinomycetemcomitans all exhibited significant antibacterial activity (71).
Figure 3. The chemical structure of (B) DHA and (A) EPA.
Periodontitis: Compounds, Primary Prevention, Underlying Mechanisms
Periodontitis is a chronic multifactorial inflammatory disease that may result from a host immune response triggered by bacterial biofilms and is characterized by inflammation of gingival tissue and resorption of alveolar bone (20, 65, 72). Periodontal disease can be treated with non-surgical as well as surgical therapies. Both supra- and subgingival plaque and calculus removal should be performed as an initial stage of the treatment of periodontal disease (65). Common pathogens of periodontitis are Treponema denticola, P. gingivalis, Tannerella forsythia, Bacteroides sp., Actinomyces sp, Staphylococcus intermedius, Actinomyces actinomycetemcomitans, and Candida albicans (72, 73). The main marine bioactive ingredients that have been reported to be beneficial for periodontal health are chitosan, sea cucumber extract, n-3 PUFAs, and algae extracts.
Chitosan is a chemically processed form of chitin (Figure 4) with the ability to S. mutans, A. actinomycetemcomitans and on P. gingivalis (74–76). Choi et al. (77) evaluated the in vitro antimicrobial properties of a chitosan (Figure 5) (72). A novel formulation based on the combination of chitosan and poly vinyl alcohol (PVA) was prepared by Wang et al. (78). Both in-vivo and in-vitro experiments demonstrated that the CM-chitosan microsphere (Cs2-Ms) is soft, more hydrophilic, and rapidly degradable by diffusion under physiological conditions. Besides, the authors pointed out that in the future, Cs2-Ms have more potential than Cs1-Ms to be used as core component of newly designed localized drug delivery system (LDDS) for the treatment of periodontitis. Sea cucumber extracts have been shown to have antibacterial effects and the compounds they contain with potential anti-inflammatory effects are saponins, which reduce the activity of COX-2, which plays a role in stimulating inflammatory mediators (12, 79–81). Hence, sea cucumber has a role in periodontitis and can be used as an alternative treatment for inflammation (81).
Figure 4. The chemical structure of (A) chitin and (B) chitosan.
Figure 5. Inhibition of bacterial activity by chitosan.
N-3 PUFAs has antibacterial and anti-inflammatory activity, which can be used for the prevention and treatment of periodontitis (82). Ribeiro-Vidal et al. (70) indicated that the results of DHA and EPA showed significant antimicrobial activity in the biofilm model of Streptococcus oralis, Actinomyces naeslundii, V. parvula, Fusobacterium nucleatum, P. gingivalis, and Aggregatibacter actinomycetemcomitans (71). As shown in Figure 6, the invasion of bacteria and their products into periodontal tissues leaded to the production of inflammatory mediators and enzymes such as IL-6, TNF-α, COX-2, etc. N-3 PUFAs were able to reduce the tendency of inflammation by competitively inhibiting the production of COX-2 and LOX (83). A study by Stańdo et al. (83) suggested that dietary intervention with high doses of n-3 PUFAs during non-surgical treatment may be helpful in the periodontitis treatment. By evaluating dietary intervention in periodontitis patients (stage III and IV), this study revealed that after 3 months of treatment, saliva samples from patients receiving n-3 PUFAs intervention showed significantly higher levels of the anti-inflammatory interleukin-10 and significantly lower levels of the pro-inflammatory cytokines interleukin-8 and interleukin-17 (83). Kruse et al. (84) used meta-analysis to evaluate the effect of n-3 PUFAs in periodontal treatment with adjunctive administration. The result showed that n-3 PUFAs appeared to have a positive effect on periodontal wound healing in terms of reduced clinical attachment level (CAL) and probing depth (PD). Based on this study, patients receiving periodontal therapy may benefit from nutritional counseling.
Figure 6. The role of n-3 PUFAs in the reduction of periodontitis.
Marine algae have recently gained popularity for their bioactive molecules and their oral applications. For example, sulfated polysaccharides (PLS) has been reported to have anti-inflammatory effects and to prevent periodontal and liver tissue changes caused by periodontitis (85). Ecklonia cava, an edible marine brown algae, whose ethanol extract (ECE) can cause tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) gene downregulated (86, 87). An Indian red alga Kappaphycus alvarezii (KAB) is rich in marine bromophenols (MBs), which can downregulate the mRNA level in the gene of P. gingivalis, and has an inhibitory effect on it. Additionally, KAB has been reported to inhibit gingipain and hemagglutination activities. As a potent natural metabolite, MBs has potential for use in dental products (88). Spirulina maxima has also been reported to be biologically active against periodontitis. Kang et al. (89) indicated that in the presence of S. maxima, inflammatory cytokines such as TNF-α, IL-1β, IL-6, and the inflammatory transcription factor NF-κB were reduced in gingival tissues, the expression of myeloperoxidase (MPO) activity and matrix metallopr oteinases (MMPs) was decreased, and osteogenic-related factors were promoted. Thus, this study showed that S. maxima reduces gingivitis-induced periodontitis and consequently bone loss through anti-inflammatory effects (89).
Oral Squamous Cell Carcinomas: Compounds, Underlying Mechanisms
The most common oral cancers are found in the oral cavity and include the lips, tongue, gums, oral mucosa, floor of the mouth, hard palate, maxilla, mandible, nasopharynx, oropharynx, and hypopharynx (90). More than 90% of oral cancers are squamous cell carcinomas (91). It is estimated that 657,000 new cases of oral cavity and throat cancer are diagnosed each year, with more than 330,000 deaths (92). There are many factors that contribute to oral cancer. Besides tobacco, heavy consumption of alcoholic beverages, inappropriate dietary habits, poor oral hygiene, chronic inflammatory processes in the oral cavity, various viruses and bacteria, dentures, mucosal trauma, and mucosal trauma from restorations are also risk factors for the development of oral squamous cell carcinoma (OSCC) (93, 94). P. gingivalis causes oral inflammation and plays an important role in the development of OSCC. This is because P. gingivalis is able to convert nitrite in saliva to nitric oxide (NO), a metabolite that regulates different cancer-related manifestations such as apoptosis, cell cycle, angiogenesis, invasion and metastasis (68, 95). Therefore, early diagnosis and treatment of periodontitis is not only beneficial for the maintenance of patients' oral health, but also important for the prevention of OSCC (68, 96).
Some marine algae contain bioactive compounds that are potential agents for OSCC treatment due to their ability to modulate the antioxidant defense system, apoptosis and autophagy in oral cancer (94). For instance, blue-green microalga Spirulina has been reported to reduce the risk of OSCC by reversing oral leukoplakias (97). In studies of anti-cancer effects, at least in part, by generating high levels of intracellular reactive oxygen species (ROS) (98). In the example of red algae, a methanolic extract of the red algae Luminacin (a marine microbial extract) induced autophagy and cell death in head and neck cancer cells (99, 100). Furthermore, a study by Yeh et al. (98) indicated that methanolic extract of Gracilaria tenuistipitata (MEGT) from seaweed extracts had apoptotic to oral cancer cells through DNA damage, ROS induction and mitochondrial depolarization. However, the above studies did not further address the anti-cancer mechanism of the specific bioactive components in the methanolic extract of the seaweed. Sporiolides A and B (Figures 7A,B) from the brown algae Actinotrichia fragilis, two new dodecameric macrolides, showed cytotoxicity against L1210 cells (101, 102). In addition, Zhang et al. (103) showed that fucoidan inhibited OSCC development by targeting filamin A (FLNA)-derived circular RNA (circFLNA) to mediate the expression of key proteins associated with cell growth, apoptosis, migration and invasion.
Figure 7. (A–E) The chemical structure of halichondrin B, sporiolide A, sporiolide B, 11-dehydrosinulariolide, and sandensolide.
Bioactive components extracted from sea hare, sponges, corals, and fish also have the potential to modulate OSCC (104). A family of cyclic and linear peptides known as dolastatins as well as depsipeptides have been isolated from sea hare (Dolabella auricularia) and have been reported to be active anticancer components. Dolastatin-H (Dolabella auricularia) and Isodolastatin-H (Dolabella auricularia) have been shown to be highly cytotoxic agents (105, 106). Other cytotoxic agents such as polypropionate, auripyrone-A and B, were also isolated from Dolabella auricularia (105). Discodermolide, isolated from sponges (Discodermia dissolute), is the most promising natural product discovered to date. Discodermolide has been shown to be more effective than taxol and is being tested for the treatment of solid tumors (107, 108).
Another antitumor marine bioactive compound is 11-dehydrosinulariolide (an active ingredient isolated from the soft coral Sinularia leptoclados), which is also a potential antitumor bioactive ingredient (109). Liu et al. (109) noted that treatment for 6 h significantly induced early and late apoptosis in CAL-27 cells, providing a clue to the biochemical mechanism of the antitumor effect of 11-dehydrosinulariolide (Figure 7C) on CAL-27 cells. Bioactive components extracted from fish, such as Lejimalides (A-D), are unique 24-membered polyene macrolides isolated from a marine tunicate Eudistoma cf. rigida, exhibit potent in vitro cytotoxic activity (110). Pardaxin (H- GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE-OH) is a 33 amino acid peptide, an antimicrobial peptide (AMP) isolated from marine fish species Pardachirus marmoratus (111–113). It is also a possible marine bioactive component for adjuvant chemotherapy in human OSCC care. Han et al. (114) pointed out that Pardaxin treatment caused cell cycle arrest in SCC-4 cells in the G2/M phase, thereby limiting cell proliferation.
Moreover, some cellular derivatives can be used to synthesize components with anticancer properties, such as E7389, a synthetic compound based on halichondrin B (Figure 7D), which was isolated from the Japanese sponge Halicondria okadai (115–117). Cheng et al. (118) investigated the effect of prodigiosin (PG), an alkaloid and natural red pigment as a secondary metabolite of Serratia marcescens on the growth inhibition of human oral squamous carcinoma cells. The results showed that PG induced autophagic cell death of OECM1 and SAS cells in vitro via the LC3-mediated P62/LC3-I/LC3-II pathway. This implied that PG might target the autophagic cell death pathway as a potential agent for cancer therapy. Furthermore, sandensolide (Figure 7E) isolated from Sinularia flexibilis also has an inhibitory effect on the growth of human OSCC cells, and its possible mechanism of action is the induction of oxidative stress-mediated cell death pathway (119).
Challenges of Marine Bioactive Compounds in Oral Health
The ocean is naturally one of the richest sources of bioactive compounds that can be used as functional ingredients in the development of products for oral health benefits. These bioactive compounds can also be incorporated into dietary supplements, nutritional products and pharmaceuticals to exploit their potential health benefits. Currently, marine based nutraceuticals mainly include fish oil (mainly n-3 PUFAs), algal oil, shark liver oil and squalene, seaweed (macroalgae) and its components, chitin, chitosan (monomers), chitosan (oligomers), enzymes, peptides, protein hydrolysates and other products (120). Indeed, dietary factors, such as nutrients with antioxidant effects, immunomodulatory effects and those related to bone metabolism, have been shown to affect periodontitis directly or interactively (121–123). The highly diverse and dynamic nature of marine ecosystems has led to the identification of marine resource compounds as an important resource for potential functional foods (8, 9). However, despite the health potential of these compounds, their bioavailability affects their effectiveness in the human organism (124). Indeed, bioactive compounds whose complex properties and absorption mechanisms are such as metabolism, digestibility, and activity after absorption, are a scientific challenge to be further investigated and clarified.
For the development of oral health products, the maturity of the preparation process, clinical studies, safety doses and risks of marine bioactive ingredients should be considered for the industrialization of marine bioactive ingredients. For example, marine derivatives such as secondary metabolites are trace amounts and natural reserves are too small to sustain widespread use and development (101). The current marine ingredients with more mature preparation processes and production procedures are n-3 PUFAs, which are effective in alleviating a wide range of health conditions (125). Therefore, n-3 PUFAs related functional foods and special diets have been at the forefront of research and development. Meanwhile, the preparation process of sea cucumber polysaccharides has been also relatively mature, the separation and purification technology has been developed, and the biological activity has been studied (42, 126). However, research on the relationship between biological activity and conformation of sea cucumber polysaccharides is still lacking, and the theoretical support as a functional food ingredient needs further improvement. Although there are more and more supporters of fucoidan as functional food ingredients so far, the structure-function relationship of rockweed polysaccharides is still controversial (127–130). The structural backbone of most fucoidan is unknown, and the location and branching sites of their specific sulfate groups have not been described, leading to structure-activity relationships for fucoidan that have yet to be elucidated. Even though the broad biological activity of fucoidan has been demonstrated, there is a lack of pharmacokinetic data and their clinical application is still limited and needs to be further promoted (131, 132).
The stability of the bioactive substance is another important consideration for its potential application. This is because various functional components in food products play an important role in improving food properties and efficacy. Bioactive substances with health benefits such as probiotics, vitamins, minerals, polyphenols, n-3 polyunsaturated fatty acids are sensitive to oxygen, light, heat, water, pH, etc., which affects the shelf life of the food and the effective release during application. Alginates is an important microcapsule for loading bioactive ingredients in the preparation of functional foods, acting as a unique emulsification, thickening, gelation, film formation and other properties have important applications in encapsulating functional food factors (127). Xiao et al. (133) investigated the encapsulation rate and slow release effect of three ratios of calcium alginate, chitosan-encapsulated calcium alginate, and chitosan-calcium alginate direct mixture on sweet orange oil. It was found that the polymerization of calcium alginate and chitosan encapsulated sweet orange oil could control the prolongation of sweet orange oil during chewing of chewing gum to the maximum extent and prolong the flavor action time of chewing gum. Overall, marine compounds have outstanding health potential can be used as a health strategy to prevent or treat diseases and benefit the maintenance of oral health in humans. Marine biological ingredients have been used in food products, but further in vivo studies and human clinical trials as well as industrial promotion are needed for more marine biological active ingredients.
Conclusion and Perspective
Oral diseases can cause pain, impaired function and reduced quality of life, resulting in considerable loss of productivity and financial burden to the patient. Dental health therefore has a direct impact on the normal life of people. Recent in vitro and in vivo studies have revealed the important role of marine bioactive components in the prevention of various oral health problems ranging from dental caries to halitosis and periodontal disease.
The studies mentioned in this review have shown that marine bioactive ingredients seaweed extracts, n-3 PUFAs, sea cucumber extracts, and marine bacterial metabolites have the ability to inhibit oral pathogens, repress their biofilms, and regulate the cancer cell cycle. Therefore, the marine bioactive ingredients mentioned in this paper such as n-3 PUFAs, sea cucumber extracts, and seaweed extracts can play a good role in inhibiting oral pathogenic bacteria, eliminating inflammation, and anti-tumor, which are good choices for developing oral functional foods, such as functional chewing gum or sugar-free tablets. However, before incorporating marine bioactive substances into functional food development, their industrial feasibility has to be evaluated and relevant studies have to be conducted to reveal the possible mechanisms of action of marine bioactive substances and long-term clinical trials.
As the global nutraceutical market grows, consumer interest in marine sourced ingredients is gradually increasing (10, 104). The potential applications of marine bioactive compounds in food, functional food and supplement development are receiving more attention. Compared to systemic diseases, oral diseases have a strong specificity and the vast majority of treatments require surgical operations for treatment, routinely contacting the patient's saliva, blood and gingival sulcus fluid. When patients carry respiratory-transmitted pathogens such as pneumonia virus, influenza virus, mycobacterium tuberculosis and other microorganisms in the oral cavity and nasopharynx, the aerosols and droplets produced can pose a serious hazard. Especially during this COVID-19 pandemic situation, many people undergoing treatment for dental diseases can be affected. Therefore, adequate oral hygiene is very important. Furthermore, with the rising awareness of oral disease prevention and dental health maintenance, functional foods and dietary supplements for oral health are favored by consumers.
In fact, a number of marine bioactive compounds have been used in the food industry as functional food ingredients to enhance the functional properties of foods or as additives to improve certain properties of foods (stability, emulsification, texture improvement). In the industrialization of marine bioactive ingredients, their bioavailability, purity, environmental friendliness, cost effectiveness, etc. are aspects that need attention. The studies on marine bioactive ingredients with mature preparation processes have been mostly focused on bioactivity exploration. Future research on two aspects of the marine bioactive ingredients is therefore recommended. On the one hand, the stability and adaptability of the activity need to be further investigated, that is, the chemical modification or organic synthesis of the structure, while preserving its physiological activity, in order to expand its application in the food field. On the other hand, the comprehensive utilization of low-value products/byproducts should be further undertaken. For example, the comprehensive utilization of polysaccharide-rich processing waste to cut down the cost of industrial applications. For the newly discovered marine biological active ingredients, further research on their functional structure, active mechanism of action, especially clinical application and even pharmacokinetic data support is needed. Furthermore, studies on health promotion, safe dosage and side effects of newly discovered compounds will also provide favorable theoretical support for their industrialization.
Author Contributions
Y-ZH: writing the article. X-PD, L-BQ, and SS: critical revision of the article. Y-ZH, X-PD, B-WZ, ZJ, and Z-MW: final approval of the article. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by the National Key Research and Development Program of China (2019YFD0902000).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgments
The authors would like to thank Yisha Xie, Dong Zhang, Youlian Li, Yumin Dong, Xiaomin Zhang, and Ziqing Zhang for their support.
References
1. Isola G. The impact of diet, nutrition and nutraceuticals on oral and periodontal health. Nutrients. (2020) 12. doi: 10.3390/nu12092724
2. Dye BA. The global burden of oral disease: research and public health significance. J Dental Res. (2017) 96:361–3. doi: 10.1177/0022034517693567
3. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. (2018) 392:1789–858. doi: 10.1016/S0140-6736(18)32279-7
4. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. (2021) 71:209–49. doi: 10.3322/caac.21660
5. Venugopal V. Nutrients and nutraceuticals from seafood. In: Mérillon J-M, Ramawat KG, ediors. Bioactive Molecules in Food. Cham: Springer International Publishing (2018). pp. 1–45.
6. Klongklaew N, Praiboon J, Tamtin M, Srisapoome P. Antibacterial and antiviral activities of local thai green macroalgae crude extracts in pacific white shrimp (Litopenaeus vannamei). Marine Drugs. (2020) 18:140. doi: 10.3390/md18030140
7. Zhu B, Ni F, Xiong Q, Yao Z. Marine oligosaccharides originated from seaweeds: source, preparation, structure, physiological activity and applications. Crit Rev Food Sci Nutr. (2021) 61:60–74. doi: 10.1080/10408398.2020.1716207
8. Lang Y, Zhao X, Liu L, Yu G. Applications of mass spectrometry to structural analysis of marine oligosaccharides. Marine Drugs. (2014) 12:4005–30. doi: 10.3390/md12074005
9. Lordan R, Tsoupras A, Zabetakis I. Phospholipids of animal and marine origin: structure, function, and anti-inflammatory properties. Molecules. (2017) 22:1964. doi: 10.3390/molecules22111964
10. Ashraf SA, Siddiqui AJ, Elkhalifa AEO, Khan MI, Patel M, Alreshidi M, et al. Innovations in nanoscience for the sustainable development of food and agriculture with implications on health and environment. Sci Total Environ. (2021) 768:144990. doi: 10.1016/j.scitotenv.2021.144990
11. Shaikh HS. Diverse application of marine components and bioactives in dentistry: a review. World J Adv Sci Res. (2020) 3:169–81.
12. Ibrahim NM, Alias A, Noraini NN, Kamarudin SS, Li AR, Hasan MKN. Sea cucumber as inhibitor of bacterial adhesion in dental plaque: would this be a possible reality? Int J Stud Childwomen Elderly Dis. (2018) 4:140–9.
13. Petersen PE. The world oral health report 2003: continuous improvement of oral health in the 21st century – the approach of the WHO global oral health programme. Commun Dent Oral Epidemiol. (2003) 31(suppl. 1):3–24. doi: 10.1046/j.2003.com122.x
14. Chauhan DN, Singh PR, Shah K, Chauhan NS. Charpter 1 natural oral care in dental therapy: current and future prospects. In: Chauhan DN, Singh PR, Kamal S, Chauhan NS, editors. Natural Oral Care in Dental Therapy. Hobken, NJ: John Wiley & Sons (2020) p. 1–29.
15. Chugh P, Dutt R, Sharma A, Bhagat N, Dhar MS. A critical appraisal of the effects of probiotics on oral health. J Funct Foods. (2020) 70:103985. doi: 10.1016/j.jff.2020.103985
16. López Y, Soto SM. The usefulness of microalgae compounds for preventing biofilm infections. Antibiotics. (2020) 9:9. doi: 10.3390/antibiotics9010009
17. Soto SM. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence. (2013) 4:223–9. doi: 10.4161/viru.23724
18. Patel M, Ashraf MS, Siddiqui AJ, Ashraf SA, Sachidanandan M, Snoussi M, et al. Profiling and role of bioactive molecules from puntius sophore (Freshwater/Brackish Fish) skin mucus with its potent antibacterial, antiadhesion, and antibiofilm activities. Biomolecules. (2020) 10:920. doi: 10.3390/biom10060920
19. Adnan M, Alshammari E, Patel M, Amir Ashraf S, Khan S, Hadi S. Significance and potential of marine microbial natural bioactive compounds against biofilms/biofouling: necessity for green chemistry. PeerJ. (2018) 6:e5049. doi: 10.7717/peerj.5049
20. Darveau RP, Curtis MA. Oral biofilms revisited: a novel host tissue of bacteriological origin. Periodontology 2000. (2021) 86:8–13. doi: 10.1111/prd.12374
21. Tiffany B, Blasi P, Catz SL, McClure JB. Mobile apps for oral health promotion: content review and heuristic usability analysis. JMIR Mhealth Uhealth. (2018) 6:e11432. doi: 10.2196/11432
22. Monedeiro F, Milanowski M, Ratiu I-A, Zmysłowski H, Ligor T, Buszewski B. VOC profiles of saliva in assessment of halitosis and submandibular abscesses using HS-SPME-GC/MS technique. Molecules. (2019) 24:2977. doi: 10.3390/molecules24162977
23. Hicks J, Garcia-Godoy F, Flaitz C. Biological factors in dental caries: role of saliva and dental plaque in the dynamic process of demineralization and remineralization (part 1). J Clin Pediatric Dent. (2008) 28:47–52. doi: 10.17796/jcpd.28.1.yg6m443046k50u20
24. Levine RS. Towards the chemotherapeutic treatment of dental caries: a review. J R Soc Med. (1980) 73:876–81. doi: 10.1177/014107688007301211
25. Dang M-H, Jung J-E, Choi H-M, Jeon J-G. Difference in virulence and composition of a cariogenic biofilm according to substratum direction. Sci Rep. (2018) 8:6244–. doi: 10.1038/s41598-018-24626-2
26. Han P, Lai A, Salomon C, Ivanovski S. Detection of salivary small extracellular vesicles associated inflammatory cytokines gene methylation in gingivitis. Int J Mol Sci. (2020) 21:5273. doi: 10.3390/ijms21155273
27. Niklaus P, Meyle J, Murakami S, Plemons J, Romito GA, Shapira L. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium. J Clin Periodontol. (2017). 45:S68–77. doi: 10.1111/jcpe.12940
28. Julkunen A, Heikkinen AM, Söder B, Söder P-Ö, Toppila-Salmi S, Meurman JH. Autoimmune diseases and oral health: 30-year follow-up of a Swedish cohort. Dent J. (2018) 6:1. doi: 10.3390/dj6010001
29. Mariotti A. Dental plaque-induced gingival diseases. Ann Periodontol. (1999) 4:7–17. doi: 10.1902/annals.1999.4.1.7
30. Burch JG, Lanese R, Ngan P. A two-month study of the effects of oral irrigation and automatic toothbrush use in an adult orthodontic population with fixed appliances. Am J Ortho Dent Ortho. (1994) 106:121–6. doi: 10.1016/S0889-5406(94)70028-1
31. Albino J, Tiwari T. Preventing childhood caries: a review of recent behavioral research. J Dental Res. (2016) 95:35–42. doi: 10.1177/0022034515609034
32. Lingström P, Lundgren F, Birkhed D, Takazoe I, Frostell G. Effects of frequent mouthrinses with palatinose and xylitol on dental plaque. Eur J Oral Sci. (1997) 105:162–9. doi: 10.1111/j.1600-0722.1997.tb00195.x
33. Ferrazzano GF, Cantile T, Coda M, Alcidi B, Sangianantoni G, Ingenito A, et al. In Vivo release kinetics and antibacterial activity of novel polyphenols-enriched chewing gums. Molecules. (2016) 21:1008. doi: 10.3390/molecules21081008
34. Isola G. Current evidence of natural agents in oral and periodontal health. Nutrients. (2020) 12:585. doi: 10.3390/nu12020585
35. Calvo-Guirado JL, Fernández Domínguez M, Aragoneses JM, Martínez González JM, Fernández-Boderau E, Garcés-Villalá MA, et al. Evaluation of new seawater-based mouth rinse versus chlorhexidine 0.2% reducing plaque and gingivitis indexes. A randomized controlled pilot study. Appl Sci. (2020) 10:982. doi: 10.3390/app10030982
36. Keukenmeester RS, Slot DE, Putt MS, Van der Weijden GA. The effect of sugar-free chewing gum on plaque and clinical parameters of gingival inflammation: a systematic review. Int J Dental Hygiene. (2013) 11:2–14. doi: 10.1111/j.1601-5037.2012.00562.x
37. Kose O, Arabaci T, Yemenoglu H, Kara A, Ozkanlar S, Kayis S, et al. Influences of fucoxanthin on alveolar bone resorption in induced periodontitis in rat molars. Marine Drugs. (2016) 14:70. doi: 10.3390/md14040070
38. Ye L, Xu L, Li J. Preparation and anticoagulant activity of a fucosylated polysaccharide sulfate from a sea cucumber acaudina molpadioidea. Carb Pol. (2012) 87:2052–7. doi: 10.1016/j.carbpol.2011.10.014
39. Wu M, Xu S, Zhao J, Kang H, Ding H. Physicochemical characteristics and anticoagulant activities of low molecular weight fractions by free-radical depolymerization of a fucosylated chondroitin sulphate from sea cucumber thelenata ananas. Food Chem. (2010) 122:716–23. doi: 10.1016/j.foodchem.2010.03.042
40. Tong Y, Zhang X, Tian F, Yi Y, Xu Q, Li L, et al. Philinopside a, a novel marine-derived compound possessing dual anti-angiogenic and anti-tumor effects. Int J Cancer. (2005) 114:843–53. doi: 10.1002/ijc.20804
41. Sansone C, Brunet C. Marine algal antioxidants. Antioxidants. (2020) 9:206. doi: 10.3390/antiox9030206
42. Qin Y, Yuan Q, Zhang Y, Li J, Zhu X, Zhao L, et al. Enzyme-assisted extraction optimization, characterization and antioxidant activity of polysaccharides from sea cucumber phyllophorus proteus. Molecules. (2018) 23:590. doi: 10.3390/molecules23030590
43. Miller TE, Dodd J, Ormrod DJ, Geddes R. Anti-inflammatory activity of glycogen extracted from Perna canaliculus (NZ green-lipped mussel). Agents Actions. (1993) 38:C139–42. doi: 10.1007/BF01991164
44. Luo L, Wu M, Xu L, Lian W, Xiang J, Lu F, et al. Comparison of physicochemical characteristics and anticoagulant activities of polysaccharides from three sea cucumbers. Marine Drugs. (2013) 11:399–417. doi: 10.3390/md11020399
45. Lee Y-N, Tai C-J, Hwang T-L, Sheu J-H. Krempfielins N–P, new anti-inflammatory eunicellins from a Taiwanese soft coral cladiella krempfi. Marine Drugs. (2014) 12:1148–56. doi: 10.3390/md12021148
46. Grienke U, Silke J, Tasdemir D. Bioactive compounds from marine mussels and their effects on human health. Food Chem. (2014) 142:48–60. doi: 10.1016/j.foodchem.2013.07.027
47. Dong X, Pan R, Deng X, Chen Y, Zhao G, Wang C. Separation, purification, anticoagulant activity and preliminary structural characterization of two sulfated polysaccharides from sea cucumber Acaudina molpadioidea and Holothuria nobilis. Pro Biochem. (2014) 49:1352–61. doi: 10.1016/j.procbio.2014.04.015
48. Choi W, Lee JB, Cui L, Li Y, Li Z, Choi JS, et al. Therapeutic efficacy of topically applied antioxidant medicinal plant extracts in a mouse model of experimental dry eye. Oxid Med Cell Longev. (2016) 2016:4727415. doi: 10.1155/2016/4727415
49. Athukorala Y, Jung W-K, Vasanthan T, Jeon Y-J. An anticoagulative polysaccharide from an enzymatic hydrolysate of ecklonia cava. Carb Pol. (2006) 66:184–91. doi: 10.1016/j.carbpol.2006.03.002
50. Loureiro DRP, Soares JX, Costa JC, Magalhães ÁF, Azevedo CMG, Pinto MMM, et al. Structures, activities and drug-likeness of anti-infective xanthone derivatives isolated from the marine environment: a review. Molecules. (2019) 24:243. doi: 10.3390/molecules24020243
51. Lee J-C, Hou M-F, Huang H-W, Chang F-R, Yeh C-C, Tang J-Y, et al. Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties. Cancer Cell Int. (2013) 13:55. doi: 10.1186/1475-2867-13-55
52. Ashraf SA, Adnan M, Patel M, Siddiqui AJ, Sachidanandan M, Snoussi M, et al. Fish-based bioactives as potent nutraceuticals: exploring the therapeutic perspective of sustainable food from the sea. Marine Drugs. (2020) 18:265. doi: 10.3390/md18050265
53. Van Houte J. Role of micro-organisms in caries etiology. J Dental Res. (1994) 73:672–81. doi: 10.1177/00220345940730031301
54. Frencken JE, Sharma P, Stenhouse L, Green D, Laverty D, Dietrich T. Global epidemiology of dental caries and severe periodontitis–a comprehensive review. J Clin Periodontol. (2017) 44:S94–105. doi: 10.1111/jcpe.12677
55. Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. (2017) 390:1211–59. doi: 10.1016/S0140-6736(17)32154-2
56. Krzyściak W, Jurczak A, Kościelniak D, Bystrowska B, Skalniak A. The virulence of Streptococcus mutans and the ability to form biofilms. Eur J Clin Microbiol Infect Dis. (2014) 33:499–515. doi: 10.1007/s10096-013-1993-7
57. Edlund A, Yang Y, Hall AP, Guo L, Lux R, He X, et al. An in vitro biofilm model system maintaining a highly reproducible species and metabolic diversity approaching that of the human oral microbiome. Microbiome. (2013) 1:1–17. doi: 10.1186/2049-2618-1-25
58. Cui C, Xu H, Yang H, Wang R, Xiang Y, Li B, et al. Antibacterial activity of fruiting body extracts from culinary-medicinal winter mushroom, flammulina velutipes (Agaricomycetes) against oral pathogen streptococcus mutans. Int J Med Mushrooms. (2020) 22:115–24. doi: 10.1615/IntJMedMushrooms.2020033335
59. Deng Y, Wang X, Guo H, Duan D. A trehalose-6-phosphate synthase gene from Saccharina japonica (Laminariales, Phaeophyceae). Mol Biol Rep. (2014) 41:529–36. doi: 10.1007/s11033-013-2888-5
60. Onyango SO, De Clercq N, Beerens K, Van Camp J, Desmet T, Van de Wiele T. Oral microbiota display profound differential metabolic kinetics and community shifts upon incubation with sucrose, trehalose, kojibiose, and xylitol. Appl Environ Microbiol. (2020) 86:e01170–20. doi: 10.1128/AEM.01170-20
61. Jun J-Y, Jung M-J, Jeong I-H, Yamazaki K, Kawai Y, Kim B-M. Antimicrobial and antibiofilm activities of sulfated polysaccharides from marine algae against dental plaque bacteria. Marine Drugs. (2018) 16:301. doi: 10.3390/md16090301
62. Jafari S, Mobasher MA, Najafipour S, Ghasemi Y, Mohkam M, Ebrahimi MA, et al. Antibacterial potential of chlorella vulgaris and Dunaliella salina extracts against Streptococcus mutans. Jundis J Nat Pharm Prod. (2018) 13:e1326. doi: 10.5812/jjnpp.13226
63. Ren W, Cai R, Yan W, Lyu M, Fang Y, Wang S. Purification and characterization of a biofilm-degradable dextranase from a marine bacterium. Marine Drugs. (2018) 16:51. doi: 10.3390/md16020051
64. Lai X, Liu X, Liu X, Deng T, Feng Y, Tian X, et al. The marine catenovulum agarivorans MNH15 and dextranase: removing dental plaque. Marine Drugs. (2019) 17:592. doi: 10.3390/md17100592
65. Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. (2018) 89(Suppl. 1):S74–84. doi: 10.1002/JPER.17-0719
66. Wen LH. Comparison of Efficacy Between Toothpastes Containing Sea Cucumber and Non-Sea Cucumber Extract on Gingivitis [dissertation]. Universitas Padjadjaran (2013).
67. Bakar NA, Jayah NI, Mohamed NR, Ali SM, Nasir SH, Hashim R, et al. The effectiveness of pure Stichopus horrens extract toothpaste in reducing plaque-induced gingivitis following orthodontic bonding: a triple-blinded randomized controlled trial. J World Federat Ortho. (2020) 9:3–8. doi: 10.1016/j.ejwf.2019.11.004
68. Cho H-B, Lee H-H, Lee O-H, Choi H-S, Choi J-S, Lee B-Y. Clinical and microbial evaluation of the effects on gingivitis of a mouth rinse containing an enteromorpha linza extract. J Med Food. (2011) 14:1670–6. doi: 10.1089/jmf.2011.1710
69. Campan P, Planchand P-O, Duran D. Pilot study on n-3 polyunsaturated fatty acids in the treatment of human experimental gingivitis. J Clin Periodontol. (1997) 24:907–13. doi: 10.1111/j.1600-051X.1997.tb01210.x
70. Ribeiro-Vidal H, Sánchez MC, Alonso-Español A, Figuero E, Ciudad MJ, Collado L, et al. Antimicrobial activity of EPA and DHA against oral pathogenic bacteria using an in vitro multi-species subgingival biofilm model. Nutrients. (2020) 12:2812. doi: 10.3390/nu12092812
71. Araujo P, Belghit I, Aarsæther N, Espe M, Lucena E, Holen EJN. The effect of omega-3 and omega-6 polyunsaturated fatty acids on the production of cyclooxygenase and lipoxygenase metabolites by human umbilical vein endothelial cells. Nutrients. (2019) 11:966. doi: 10.3390/nu11050966
72. How KY, Song KP, Chan KG. Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol. (2016) 7:627. doi: 10.3389/fmicb.2016.00053
73. Llambés F, Arias-Herrera S, Caffesse R. Relationship between diabetes and periodontal infection. World J Diabetes. (2015) 6:927–35. doi: 10.4239/wjd.v6.i7.927
74. Christensen ND, Reed CA, Culp TD, Hermonat PL, Howett MK, Anderson RA, et al. Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate. Antimicro Agents Chemother. (2001) 45:3427. doi: 10.1128/AAC.45.12.3427-3432.2001
75. Elbi S, Nimal TR, Rajan VK, Baranwal G, Biswas R, Jayakumar R, et al. Fucoidan coated ciprofloxacin loaded chitosan nanoparticles for the treatment of intracellular and biofilm infections of Salmonella. Coll Surfaces B Bio. (2017) 160:40–7. doi: 10.1016/j.colsurfb.2017.09.003
76. Oggu GS, Velidandla S, Ealla KKR, Venkatesan J, Asthana A, Kim S-K, et al. Marine biomaterial treasure and biomedical sciences. In: Se-Kwon K, editor. Encyclopedia of Marine Biotechnology. John Wiley & Sons Ltd. (2020) p. 1209–29.
77. Choi B-K, Kim K-Y, Yoo Y-J, Oh S-J, Choi J-H, Kim C-Y. In vitro antimicrobial activity of a chitooligosaccharide mixture against Actinobacillus actinomycetemcomitans and Streptococcus mutans. Int J Antimicro Agents. (2001) 18:553–7. doi: 10.1016/S0924-8579(01)00434-4
78. Wang LC, Wu H, Chen XG, De Li L, Ji QX, Liu CS, et al. Biological evaluation of a novel chitosan-PVA-based local delivery system for treatment of periodontitis. J Biomed Mat Res Part A. (2009) 91A:1065–76. doi: 10.1002/jbm.a.32294
79. Šimat V, Elabed N, Kulawik P, Ceylan Z, Jamroz E, Yazgan H, et al. Recent advances in marine-based nutraceuticals and their health benefits. Marine Drugs. (2020) 18:3567–75. doi: 10.3390/md18120627
80. Zhao Y-C, Xue C-H, Zhang T-T, Wang Y-M. Saponins from sea cucumber and their biological activities. J Agric Food Chem. (2018) 66:7222–37. doi: 10.1021/acs.jafc.8b01770
81. Sukmana I, Putra AP. Use of sea cucumber extract as an alternative treatment of inflammation by chronic periodontitis. Int J Pharmac Res. (2020) 12:2614. doi: 10.31838/ijpr/2020.12.04.489
82. Beyer K, Lie SA, Kjellevold M, Dahl L, Brun JG, Bolstad AI. Marine ω-3, vitamin D levels, disease outcome and periodontal status in rheumatoid arthritis outpatients. Nutrition. (2018) 55-56:116–24. doi: 10.1016/j.nut.2018.03.054
83. Stańdo M, Piatek P, Namiecinska M, Lewkowicz P, Lewkowicz N. Omega-3 polyunsaturated fatty acids EPA and DHA as an adjunct to non-surgical treatment of periodontitis: a randomized clinical trial. Nutrients. (2020) 12:1143. doi: 10.3390/nu12092614
84. Kruse AB, Kowalski CD, Leuthold S, Vach K, Ratka-Krüger P, Woelber JP. What is the impact of the adjunctive use of omega-3 fatty acids in the treatment of periodontitis? A systematic review and meta-analysis. Lipids Health Dis. (2020) 19:1–16. doi: 10.1186/s12944-020-01267-x
85. Da Silva FRP, E Silva Conceição Pinto M, De Carvalho França LF, Alves EHP, Dos Santos Carvalho J, Di Lenardo D, et al. Sulfated polysaccharides from the marine algae gracilaria caudata prevent tissue damage caused by ligature-induced periodontitis. Int J Biol Macro. (2019) 132:1–8. doi: 10.1016/j.ijbiomac.2019.03.194
86. Kim S, Choi S-I, Kim G-H, Imm J-Y. Anti-inflammatory effect of ecklonia cava extract on porphyromonas gingivalis lipopolysaccharide-stimulated macrophages and a periodontitis rat model. Nutrients. (2019) 11:2735. doi: 10.3390/nu11051143
87. Ashraf SA, Elkhalifa AEO, Siddiqui AJ, Patel M, Awadelkareem AM, Snoussi M, et al. Cordycepin for health and wellbeing: a potent bioactive metabolite of an entomopathogenic medicinal fungus cordyceps with its nutraceutical and therapeutic potential. Molecules. (2020) 25:2331–53. doi: 10.3390/molecules25122735
88. Cherian C, Jannet Vennila J, Sharan L. Marine bromophenols as an effective inhibitor of virulent proteins (peptidyl arginine deiminase, gingipain R and hemagglutinin A) in porphyromas gingivalis. Arch Oral Biol. (2019) 100:119–28. doi: 10.1016/j.archoralbio.2019.02.016
89. Kang MS, Moon J-H, Park SC, Jang YP, Choung SY. Spirulina maxima reduces inflammation and alveolar bone loss in porphyromonas gingivalis-induced periodontitis. Phytomedicine. (2021) 81:153420. doi: 10.1016/j.phymed.2020.153420
90. Mascolo M, Siano M, Ilardi G, Russo D, Merolla F, Rosa GD, et al. Epigenetic disregulation in oral cancer. Int J Mol Sci. (2012) 13:164–9. doi: 10.3390/ijms13022331
91. Wang L, Song Y, Wang H, Liu K, Shao Z, Shang Z. MiR-210-3p-EphrinA3-PI3K/AKT axis regulates the progression of oral cancer. J Cell Mol Med. (2020) 24:4011–22. doi: 10.1111/jcmm.15036
92. Montero PH, Patel SG. Cancer of the oral cavity. Surg Oncol Clin. (2015) 24:491–508. doi: 10.1016/j.soc.2015.03.006
93. Schwartz J, Shklar G, Reid S, Trickier D. Prevention of experimental oral cancer by extracts of spirulina-dunaliella algae. Nutr Cancer. (1988) 11:127–34. doi: 10.1080/01635588809513979
94. Pradhan B, Patra S, Behera C, Nayak R, Patil S, Bhutia SK, et al. Enteromorpha compressa extract induces anticancer activity through apoptosis and autophagy in oral cancer. Mol Biol Rep. (2020) 47:9567–78. doi: 10.1007/s11033-020-06010-4
95. Angarita-Díaz MP, Forero-Escobar D, Cerón-Bastidas XA, Cisneros-Hidalgo CA, Dávila-Narvaez F, Bedoya-Correa CM, et al. Effects of a functional food supplemented with probiotics on biological factors related to dental caries in children: a pilot study. Eur Arch Paed Dent. (2020) 21:161–9. doi: 10.1007/s40368-019-00468-y
96. Achmad H, Huldani, Yunita FR. Antimicrobial activity and sulfated polysaccharides antibiofilms in marine algae against dental plaque bacteria: a literature review. Syst Rev Pharmacy. (2020) 11:459–65. doi: 10.31838/srp.2020.6.72
97. Mathew B, Sankaranarayanan R, Nair PP, Varghese C, Somanathan T, Amma BP, et al. Evaluation of chemoprevention of oral cancer with spirulina fusiformis. Nutr Cancer. (1995) 24:197–202. doi: 10.1080/01635589509514407
98. Yeh C-C, Yang J-I, Lee J-C, Tseng C-N, Chan Y-C, Hseu Y-C, et al. Anti-proliferative effect of methanolic extract of Gracilaria tenuistipitata on oral cancer cells involves apoptosis, DNA damage, and oxidative stress. BMC Compl Altern Med. (2012) 12:142. doi: 10.1186/1472-6882-12-142
99. Chang Y-T, Huang C-Y, Tang J-Y, Liaw C-C, Li R-N, Liu J-R, et al. Reactive oxygen species mediate soft corals-derived sinuleptolide-induced antiproliferation and DNA damage in oral cancer cells. Onco Targets Ther. (2017) 10:3289–97. doi: 10.2147/OTT.S138123
100. Shin YS, Cha HY, Lee B-S, Kang SU, Hwang HS, Kwon HC, et al. Anti-cancer effect of luminacin, a marine microbial extract, in head and neck squamous cell carcinoma progression via autophagic cell death. Cancer Res Treat. (2016) 48:738–52. doi: 10.4143/crt.2015.102
101. Murti Y, Agrawal T. Marine derived pharmaceuticals-Development of natural health products from marine biodiversity. Int J ChemTech Res. (2021) 2:974–4290.
102. Shigemori H, Kasai Y, Komatsu K, Tsuda M, Mikami Y, Kobayashi Ji. Sporiolides A and B, new cytotoxic twelve-membered macrolides from a marine-derived fungus cladosporium species. Marine Drugs. (2004) 2:1254–72. doi: 10.3390/md204164
103. Zhang N, Gao L, Ren W, Li S, Zhang D, Song X, et al. Fucoidan affects oral squamous cell carcinoma cell functions in vitro by regulating FLNA-derived circular RNA. Annals N Y Acad Sci. (2020) 1462:65–78. doi: 10.1111/nyas.14190
104. Surti M, Patel M, Adnan M, Moin A, Ashraf SA, Siddiqui AJ, et al. Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study. RSC Adv. (2020) 10:37707–20. doi: 10.1039/d0ra06379g
105. Suenaga K, Kigoshi H, Yamada K. Auripyrones A and B, cytotoxic polypropionates from the sea hare Dolabella auricularia: Isolation and structures. Tetrahedron Lett. (1996) 37:5151–4. doi: 10.1016/0040-4039(96)01041-6
106. Sone H, Kondo T, Kiryu M, Ishiwata H, Ojika M, Yamada K. Dolabellin, a cytotoxic bisthiazole metabolite from the sea hare dolabella auricularia: structural determination and synthesis. J Org Chem. (1995) 60:4774–81. doi: 10.1021/jo00120a021
107. Guo B, Rodriguez-Gabin A, Prota AE, Mühlethaler T, Zhang N, Ye K, et al. Structural refinement of the tubulin ligand (+)-Discodermolide to attenuate chemotherapy-mediated senescence. Mol Pharmacol. (2020) 98:156. doi: 10.1124/mol.119.117457
108. Serrano-del Valle A, Reina-Ortiz C, Benedi A, Anel A, Naval J, Marzo I. Future prospects for mitosis-targeted antitumor therapies. Biochem Pharmacol. (2021) 190:114655. doi: 10.1016/j.bcp.2021.114655
109. Liu C-I, Chen C-C, Chen J-C, Su J-H, Huang HH, Chen JY-F, et al. Proteomic analysis of anti-tumor effects of 11-Dehydrosinulariolide on CAL-27 Cells. Marine Drugs. (2011) 9:1254–72. doi: 10.3390/md9071254
110. Ramesh C, Tulasi BR, Raju M, Thakur N, Dufossé L. Marine natural products from tunicates and their associated microbes. Marine Drugs. (2021) 19:308. doi: 10.3390/md19060308
111. Dyshlovoy SA. Recent updates on marine cancer-preventive compounds. Marine Drugs. (2021) 19:558. doi: 10.3390/md19100558
112. Cipolari OC, de Oliveira Neto XA, Conceição K. Fish bioactive peptides: a systematic review focused on sting and skin. Aquaculture. (2020) 515:734598. doi: 10.1016/j.aquaculture.2019.734598
113. Pandey S, Upadhyay R. Fish venom toxins: natural source of pharmaceuticals and therapeutic agents "pharmaceutical and therapeutic uses of fish venom toxins. Int J Pharm Pharmac Sci. (2020) 12:14. doi: 10.22159/ijpps.2020v12i11.38215
114. Han Y, Cui Z, Li Y-H, Hsu W-H, Lee B-H. In Vitro and in Vivo anticancer activity of pardaxin against proliferation and growth of oral squamous cell carcinoma. Marine Drugs. (2016) 14:2. doi: 10.3390/md14010002
115. Xiu-Li S, Yin-Rong X, Ning Z, Cheng-Ting Z, Xuan-Jun W, Jun S. Recent advances on small-molecule tubulin inhibitors. Med Res. (2021) 5:200024–. doi: 10.21127/yaoyimr20200024
116. Pedersini R, di Mauro P, Amoroso V, Parati MC, Turla A, Ghilardi M, et al. Efficacy of Eribulin mesylate in older patients with breast cancer: a pooled analysis of clinical trial and real-world data. J Geriatric Oncol. (2020) 11:976–81. doi: 10.1016/j.jgo.2020.03.021
117. Jordan MA, Kamath K, Manna T, Okouneva T, Miller HP, Davis C, et al. The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth. Mol Cancer Ther. (2005) 4:1086. doi: 10.1158/1535-7163.MCT-04-0345
118. Cheng M-F, Lin C-S, Chen Y-H, Sung P-J, Lin S-R, Tong Y-W, et al. Inhibitory growth of oral squamous cell carcinoma cancer via bacterial prodigiosin. Marine Drugs. (2017) 15:224. doi: 10.3390/md15070224
119. Yu C-I, Chen C-Y, Liu W, Chang P-C, Huang C-W, Han K-F, et al. Sandensolide induces oxidative stress-mediated apoptosis in oral cancer cells and in zebrafish xenograft model. Marine Drugs. (2018) 16:387. doi: 10.3390/md16100387
120. Shahidi F, Ambigaipalan P. Novel functional food ingredients from marine sources. Curr Opin Food Sci. (2015) 2:123–9. doi: 10.1016/j.cofs.2014.12.009
121. Quiles JL, Varela-López A. The role of nutrition in periodontal diseases. In: Ekuni D, Battino M, Tomofuji T, Putnins E, editors. Studies on Periodontal Disease. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press. New York, NY: Springer. (2014). p. 251–78.
122. Younes I, Rinaudo M. Chitin and chitosan preparation from marine sources. Structure, Properties and Applications. Marine Drugs. (2015) 13:1133–74. doi: 10.3390/md13031133
123. Vitale GA, Coppola D, Palma Esposito F, Buonocore C, Ausuri J, Tortorella E, et al. Antioxidant molecules from marine fungi: methodologies and perspectives. Antioxidants. (2020) 9:1183. doi: 10.3390/antiox9121183
124. Nova P, Pimenta-Martins A, Laranjeira Silva J, Silva AM, Gomes AM, Freitas AC. Health benefits and bioavailability of marine resources components that contribute to health – what's new? Crit Rev Food Sci Nutr. (2020) 60:3680–92. doi: 10.1080/10408398.2019.1704681
125. Zhang T-T, Xu J, Wang Y-M, Xue C-H. Health benefits of dietary marine DHA/EPA-enriched glycerophospholipids. Prog Lipid Res. (2019) 75:100997. doi: 10.1016/j.plipres.2019.100997
126. Ullah S, Khalil AA, Shaukat F, Song Y. Sources, extraction and biomedical properties of polysaccharides. Foods. (2019) 8:304. doi: 10.3390/foods8080304
127. Li B, Lu F, Wei X, Zhao R. Fucoidan: structure and bioactivity. Molecules. (2008) 13:1671–95. doi: 10.3390/molecules13081671
128. Xu X, Chang Y, Xue C, Wang J, Shen J. Gastric protective activities of sea cucumber fucoidans with different molecular weight and chain conformations: a structure–activity relationship investigation. J Agric Food Chem. (2018) 66:8615–22. doi: 10.1021/acs.jafc.8b01497
129. Zong A, Cao H, Wang F. Anticancer polysaccharides from natural resources: a review of recent research. Carb Pol. (2012) 90:1395–410. doi: 10.1016/j.carbpol.2012.07.026
130. Wang Y, Xing M, Cao Q, Ji A, Liang H, Song S. Biological activities of fucoidan and the factors mediating its therapeutic effects: a review of recent studies. Marine Drugs. (2019) 17:183. doi: 10.3390/md17030183
131. Wang J, Liu L, Zhang Q, Zhang Z, Qi H, Li P. Synthesized oversulphated, acetylated and benzoylated derivatives of fucoidan extracted from Laminaria japonica and their potential antioxidant activity in vitro. Food Chem. (2009) 114:1285–90. doi: 10.1016/j.foodchem.2008.10.082
132. Wang T, Jónsdóttir R, Ólafsdóttir G. Total phenolic compounds, radical scavenging and metal chelation of extracts from icelandic seaweeds. Food Chem. (2009) 116:240–8. doi: 10.1016/j.foodchem.2009.02.041
Keywords: marine bioactive compounds, oral health, dental caries, chewing gum, functional food
Citation: Huang Y-Z, Jin Z, Wang Z-M, Qi L-B, Song S, Zhu B-W and Dong X-P (2021) Marine Bioactive Compounds as Nutraceutical and Functional Food Ingredients for Potential Oral Health. Front. Nutr. 8:686663. doi: 10.3389/fnut.2021.686663
Received: 27 March 2021; Accepted: 08 November 2021;
Published: 02 December 2021.
Edited by:
Jian Zhong, Shanghai Ocean University, ChinaReviewed by:
Mona Elena POPA, University of Agronomic Sciences and Veterinary Medicine, RomaniaMohd Adnan, University of Hail, Saudi Arabia
Jiuhong Zhang, Southeastern Oklahoma State University, United States
Ashish Shrestha, B.P. Koirala Institute of Health Sciences, Nepal
Copyright © 2021 Huang, Jin, Wang, Qi, Song, Zhu and Dong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiu-Ping Dong, ZHhpdXBpbmcmI3gwMDA0MDsxNjMuY29t